GlassScriptPhysician profile
Baskaran Joshua
NPI 1891730040
$3,046.83
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $1,042 · 2021: $137 · 2022: $21.94.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $606.78 | 2019-2022 | |
| Amgen INC. | $512.65 | 2019-2020 | |
| Pfizer INC. | $262.68 | 2019-2020 | |
| Ucb, INC. | $261.70 | 2019-2021 | |
| Radius Health, INC. | $224.96 | 2019-2020 | |
| Lilly USA, LLC | $211.15 | 2019-2020 | |
| Abbvie INC. | $182.84 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $132.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $100.76 | 2019 | |
| Mallinckrodt Enterprises LLC | $55.07 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.81 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.61 | 2019-2020 | |
| Glaxosmithkline, LLC. | $47.06 | 2019 | |
| Sobi, INC | $45.64 | 2019-2020 | |
| Horizon Therapeutics Plc | $44.43 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $41.02 | 2019 | |
| Merck Sharp & Dohme LLC | $40.89 | 2019 | |
| Genzyme Corporation | $38.97 | 2020 | |
| Celgene Corporation | $34.75 | 2019 | |
| Janssen Biotech, INC. | $26.64 | 2019 | |
| Mylan Institutional INC. | $22.08 | 2019 | |
| Astellas Pharma US INC | $21.05 | 2019 | |
| Seagen INC. | $18.87 | 2020 | |
| Incyte Corporation | $18.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baskaran Joshua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.